Risk Factors for Liver Function Deterioration after Transarterial Chemoembolization Refractoriness in Child-Pugh Class A Hepatocellular Carcinoma Patients

Risk Factors for Liver Function Deterioration after Transarterial Chemoembolization Refractoriness in Child-Pugh Class A Hepatocellular Carcinoma Patients

Background/Aims: A switch to systemic therapy, such as sorafenib, should be considered for hepatocellular carcinoma (HCC) patients refractory to transarterial chemoembolization (TACE). On the other hand, treatment changes are difficult if the liver function worsens to Child-Pugh B or C. Therefore, p...

Full description

Bibliographic Details
Main Authors: Kang Hyun Park, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Byung Chul Yoo, Jin Ho Hwang, Sang Woo Park, Young Jun Kim, Hee Sun Park, Mi Hye Yu, Hae Jeong Jeon
Format: Article
Language:English
Published: Jin Publishing & Printing Co. 2020-03-01
Series:The Korean Journal of Gastroenterology
Subjects:
carcinoma
hepatocellular
chemoembolization
therapeutic
Online Access:http://www.kjg.or.kr/journal/view.html?uid=5557&vmd=Full&

Similar Items

Similar Items